Keros Therapeutics (KROS) Cash & Equivalents (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Cash & Equivalents (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Keros Therapeutics | 383.01 Mn | 95.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.56% |
| Sep 30, 2025 | 0.47% |
| Jun 30, 2025 | -4.21% |
| Mar 31, 2025 | 28.68% |
| Dec 31, 2024 | 5.51% |
| Sep 30, 2024 | 30.75% |
| Jun 30, 2024 | -8.27% |
| Mar 31, 2024 | 33.61% |
| Dec 31, 2023 | 15.02% |
| Sep 30, 2023 | -10.60% |
| Jun 30, 2023 | -8.37% |
| Mar 31, 2023 | 25.94% |
| Dec 31, 2022 | 16.55% |
| Sep 30, 2022 | 11.04% |
| Jun 30, 2022 | -5.67% |
| Mar 31, 2022 | -0.63% |
| Dec 31, 2021 | 3.93% |
| Sep 30, 2021 | -6.65% |
| Jun 30, 2021 | -7.09% |
| Mar 31, 2021 | -4.01% |